THE DRIPBAR · TOWN HALL · MAY 2026

Marketing & Advertising
Compliance Standards

Network-wide standards for health claims, testimonials, peptide compliance, and paid advertising. Protecting our LegitScript certification and keeping campaigns live.

111+
Locations
6
Platforms
1
Certification to Protect
I. CORE PRINCIPLE

LegitScript certification is necessary
but not sufficient.

Think of it like a driver's license — it gets you on the road, but you still have to follow each platform's rules and the broader FDA/FTC landscape.

🏛
FDA / FTC
Federal guidelines on claims, testimonials, and health advertising
📱
Platform Rules
Google, Meta, Microsoft each layer their own policies on top
✓
LegitScript
Certification baseline that enables paid advertising across all platforms
⚡
When uncertain, default to the more conservative position. This principle applies to every section of this presentation.
II. CLAIMS STANDARDS

What You Can and Cannot Claim

✗
No Outcome Claims
Weight-loss percentages, symptom resolution, performance results are non-compliant unless backed by a clinical trial — across all service lines.
✗
"Results Not Typical" Is Dead
The FDA and FTC have moved well past disclaimer-based cover for atypical results. This no longer protects you.
✓
Position on Value
Anchor messaging in access, cost, quality of service, clinical oversight, and the care experience — not specific results.
✓
Structure-Function Language
Use "supports," "promotes," "helps maintain," and "aids." Always pair with the FDA disclaimer.
III. TESTIMONIALS & BEFORE/AFTER

The Rules Have Changed

  • No before/after photos in ads. Not ever, in any paid creative.
  • Landing pages only with full disclosure: real person, atypical-result notice, paid relationship.
  • Stories must be representative. Outlier transformations are non-compliant.
  • Disclose all paid relationships per FTC requirement.
✓ Compliant
"I feel my overall health improved after working with the clinic team."
"The staff was knowledgeable and the experience was comfortable."
✗ Non-Compliant
"After my peptide treatment, my condition went away."
"I lost 30 pounds in 6 weeks with their weight loss program."
IV. SERVICE-LINE MESSAGING

Category-Specific Rules

GLP-1 / Weight Loss
Do not claim compounded semaglutide is equivalent to or a replacement for the branded version.

Position around access, cost, and clinical oversight — not outcomes.
Peptides
Each peptide requires its own FDA-position check. There is no blanket approval.

Do not name specific Category 2 compounds publicly.
TRT / HRT
Never message as performance enhancement — regulators watch for this specifically.

Classify as telemedicine provider on platforms.
V. PEPTIDE COMPLIANCE — ACTION REQUIRED

Why This Matters Right Now

Platforms and regulators are actively scanning for violations. A single non-compliant post is exactly what LegitScript, Meta, and Google are looking for.

308%
Growth in non-FDA approved
peptide ads (2024 vs 2023)
75%
Growth in peptide-related
social media content
111+
Locations that share
one LegitScript certification
⚠
A flagged post from one location has the potential to affect brand-level certification status. This is why this is a network-wide communication.
V. PEPTIDE COMPLIANCE

Five Areas of Exposure

🏛 FDA & State Regulatory
Formal warning letters are public record. State boards act independently — no federal trigger required.
✓ LegitScript Monitoring
Monitors the entire commercial internet. One location can affect brand-level certification.
📱 Platform Account Risk
Content promoting unapproved compounds triggers account restrictions — affecting all ads, not just peptides.
💳 Payment Processing
Mastercard BRAM (updated June 2025) targets merchants promoting unapproved pharmaceuticals.
🌐 Brand Exposure
Content from any location is visible to regulators, competitors, and the public. It reflects on The DRIPBaR brand regardless of intent.
WHAT YOU CAN DO
  • Use "peptide therapy" or "peptide-based protocols"
  • Use "supports," "promotes," "helps maintain" + FDA disclaimer
  • Educate clients one-on-one in consultations
  • Use approved DRIPBaR marketing materials
  • Keep testimonials on overall experience & wellness
  • Say "cutting-edge peptide therapies" or "learn about the science"
WHAT YOU MUST NOT DO
  • Name specific Category 2 peptide compounds publicly
  • Make disease or outcome claims ("treats," "cures," "prevents")
  • Use implied outcome language ("melt fat," "reverse aging")
  • Share third-party content naming Category 2 compounds
  • Assume availability = public promotion rights
  • Compare to branded pharmaceutical products
VI. PAID ADVERTISING — GEOTARGETING

The Biggest Multi-Location Risk

Google's geo-targeting defaults to "presence or interest" — meaning anyone who has merely searched for a target location becomes eligible to see the ad. This quietly breaks location-level targeting across our network.

1. Disable Expansion
Turn off "presence or interest" on every campaign. Use presence-only targeting.
2. Dual Targeting
Apply both positive AND negative geotargeting on every campaign — "run here" and "do not run here."
3. Confirm Network-Wide
Each location advertises only within its licensed and served area. Verify across all accounts.
VI. PAID ADVERTISING

Disapproval Readiness & Creative Pipeline

⚡
Expect Automated Flagging
Healthcare ads will be flagged. This is normal — speed of dispute is what matters. Most disapprovals clear on human review.
📋
Pre-Load Documentation
LegitScript cert, state licensing docs, and authorization letter on company letterhead — ready to attach per account for instant disputes.
🔄
Deep Creative Pipeline
Keep approved backups so a single flagged ad set doesn't halt a campaign. Vary creative to reduce single-point-of-failure risk.
🧩
Modular Value Props
Build iterable creative from cost/access-based (less regulated) to fully regulated — so creative can be swapped quickly.
VII. GOVERNANCE & OPERATING DISCIPLINE

How We Maintain This

👤
Compliance Ownership
Clinical & Commercial Integration (Jane Martin) owns final compliance decisions. All claims and testimonials route through compliance before publishing.
📊
Regular Audits
Live ads, social content, and website pages audited regularly against latest platform, FDA, and FTC guidance.
📁
Version-Controlled Standards
This document lives in the corporate ClickUp vault with a defined review cadence as regulations evolve.
🚀
Operational Readiness
Compliance standards incorporated into the opening checklist for all new locations — consistent adoption from day one.
ACTION REQUIRED

Review Your Content Now.

Review your social media profiles, website content, and active digital advertising today. Remove anything that publicly names or promotes Category 2 or non-FDA approved peptide compounds. Do not wait.

🔍
Audit Content
Review all public-facing content across every channel
🗑
Remove Violations
Take down non-compliant content immediately
🎟
Submit Questions
If unsure, submit a ticket through IVy — don't guess
COMPLIANCE: Jane Martin (Jane@TheDRIPBaR.com)  ·  IT: Dikalo Chie (dikalo@thedripbar.com)